SBFM
Sunshine BiopharmaCNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
Current thesis
Composite grade C from latest DB weights. Momentum 41.5 / Value 57.4
Posture
Mixed
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta +0.5.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
42
Value
57
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-02 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-06-02
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $6.00
Why
Momentum42 · Δ7d -
Value57 · Δ7d +0.5
SentimentN/A · Δ7d -
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Lead driver: Value · See fundamentals
Momentum
42
52% active weight
Current posture
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Value
57
48% active weight
Current posture
7d trendFlat
Δ7d
+0.5
Δ21d
+0.3
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade C. Momentum 41.5 / Value 57.4
Fundamentals (TTM)As of 2026-06-02
Fundamentals (TTM)
As of 2026-06-02
Market Cap
$5.52M
Beta
1.71
Shares Out
4.91M
P/E (TTM) · Derived
-0.2
P/S (TTM)
0.17
P/FCF (TTM) · Derived
-0.49
Rev YoY
+11.6%
EPS YoY
+79.5%
Gross Margin
+33.0%
Op Margin
-17.3%
Net Debt
-$9.69M
Current Ratio
4.20
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology